Spinraza is a drug that is indicated for the treatment of cases of spinal muscular atrophy, since it acts in the production of SMN protein, which the person with this disease needs, which will reduce the loss of motor nerve cells, improving strength and muscle tone.
This medication can be obtained for free from SUS in the form of an injection, and must be administered every 4 months, to prevent the development of the disease and relieve symptoms. In several studies carried out, more than half of the children who had been treated with Spinraza showed significant progress in their development, namely in the control of the head and other abilities such as crawling or walking.
What is it for
This medication is indicated for the treatment of spinal muscular atrophy, in adults and children, especially when other forms of treatment do not show results.
How to use
The use of Spinraza can only be done at the hospital, by a doctor or nurse, since it is necessary to inject the medicine directly into the space where the spinal cord is.
Usually, treatment is done with 3 initial doses of 12 mg, separated by 14 days, followed by another dose 30 days after the 3rd and 1 dose every 4 months, for maintenance.
Possible side effects
The main side effects of using this medicine are related to the injection of a substance directly into the spinal cord, and not exactly with the substance of the medicine, and include headache, back pain and vomiting.
Who should not use
There are no contraindications for the use of Spinraza, and it can be used in almost all cases, as long as there is no hypersensitivity to any of the components of the formula and after the doctor's evaluation.
